Table 3

Previously published results of PAX8 expression in ovary mucinous tumours (positive/total cases)

Previous studiesAntibodiesOvary benign mucinous tumoursOvary benign/borderline mucinous tumoursOvary mucinous carcinomas
Bowen et al19α-mPax8-bIII,pAb*NDND2/18
Nonaka et al14RpAb†NDND1/12
Köbel et al22α-mPax8-bIII,pAb*NDND2/31
Tabrizi et al21pAb*NDND0/30
Laury et al15RpAb†NDND10/25
Tong et al29RpAb†NDND0/2
Tacha et al18RpAb‡0/1ND27/54
Ozcan et al13RpAb†ND6/312/9
Chu et al20RpAb§NDND9/19
Liliac et al23RpAb†NDND4/13
Total (%)0/1(0)6/31 (19.4)57/213 (26.76)
  • *Non-commercial.

  • †Proteintech Group Inc.

  • ‡Biocare Medical.

  • §Cell Marque.

  • ND, not done; pAb, polyclonal antibody; RpAb, recombinant polyclonal antibody.